Combination chemotherapy for 418 cases of advanced cancer.
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D049669:History, 16th Century; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D013997:Time Factors; D014062:Tongue Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006834:Hydrazines; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate